Pivagabine: A novel psychoactive drug

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 11 11A, 1997, Pages 1306-1309

  Esposito, Gaetano ^a   Luparini, Maria Rita ^a  

^a Università Politecnica delle Marche ACRAF Gruppo Angelini   (Italy)

Author keywords

Adjustment disorders; CAS 69542 93 4; Corticotropin releasing factor; Neurosteroids; Pivagabine; Tonerg

Indexed keywords

4 AMINOBUTYRIC ACID; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; APAMIN; CITALOPRAM; CORTICOTROPIN RELEASING FACTOR; DIHYDROALPRENOLOL; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FLUNITRAZEPAM; FORSKOLIN; GLYCINE; KAINIC ACID; KETANSERIN; LEUKOTRIENE B4; LEUKOTRIENE D4; MEPYRAMINE; METHYLCARBACHOL; NEUROTRANSMITTER RECEPTOR; NITRENDIPINE; OMEGA CONOTOXIN; PHORBOL DIBUTYRATE; PIRENZEPINE; PIVAGABINE; PRAZOSIN; PSYCHOTROPIC AGENT; RADIOLIGAND; SEROTONIN; STRYCHNINE; SULPIRIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN HOMOGENATE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG STRUCTURE; DRUG URINE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; LIGAND BINDING; MALE; MENTAL STRESS; MOUSE; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RAT; RECEPTOR AFFINITY;

ANIMALS; BRAIN CHEMISTRY; GAMMA-AMINOBUTYRIC ACID; HUMANS; PSYCHOTROPIC DRUGS;

EID: 0031438902     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. DSM IV - American Psychiatric Association, 4th edition, Washington, D.C. (1994)
2. Galzigna, L., Garbin, L., Bianchi, M. et al., Arch. Int. Pharmacod. T. 235, 73 (1978)
3. Galzigna, L., Manani, G., Garbin, L. et al., Aggressologie 22, 219 (1981)
4. Scapagnini, U., Matera, M., Arzneim.-Forsch./Drug Res. 47 (II), 1310 (1997)
5. De Marsanich, B., Amassari-Teule, M., V Convegno Nazionale - Societá Italiana di Neuroscienze (1996)
6. Swinyard, E. A., Brown, T. C., Goodman, L. S., J. Pharmacol. Exp. Ther. 106, 319 (1952)
7. Krall, E., Epilepsia 19, 409 (1978)
8. Lippa, A. S., Regan, B., Life Sci. 21, 1779 (1977)
9. Kerley, T. L., Richards, A. B., Begley, R. W. et al., J. Pharmacol. Exp. Ther. 132, 360 (1961)
10. Perez de la Mora, M., Tapia, R., Biochem. Pharmacol. 22, 2635 (1973)
11. Nova Screen® Profile Receptor Assay List by Nova Pharmaceutical Corporation, Baltimore, MD (1991)
12. Jacoby, W. B., Methods Enzymol. 5, 771 (1962)
13. Fonda, M. L., Methods Enzymol. 113, 11 (1985)
14. Fisher, L. A., TiPS 10, 189 (1989)
15. Chappell, P. B., Smith, M. A., Kilts, C. D. et al., Neurosci. 6, 2908 (1986)
16. Valentino, R. J., in: Corticotropin Releasing Factor: Basic and Clinical Studies of a Neuropeptide, E. B. De Souza, C. B. Nemeroff (eds.), p. 217, CRC Press Boca Raton, Florida, USA (1990)
17. Cabib, S., Algeri, S., Perego, C. et al., Physiol. Behav. 47, 749 (1990)
18. Cabib, S., Kempf, E., Shleef, C. et al., Brain Res. 441, 153 (1988)
19. Cabib, S., Puglisi-Allegra, S., Oliverio, A., Brain Res. 298, 138 (1984)
20. Biggio, G., Concas, A., Mostellino, M. C. et al., The brain: Source and target for Sex Steroid Hormones, A. R. Genazzani, F. Petraglia, R. H. Purdy (eds.), Parthenon Publ. Group, Casterton Hall. Lanes, UK (1996)
21. Biggio, G., Concas, A., Serra, M. et al., Proc. Int. Congress "Stress of Life", Budapest, July 1-5, 1997 (in press)